EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice

Yujie Cao, Yasmin Lewis, Lisa Tu, Lauren R Alesi, Jessica M Stringer, Nadeen Zerafa, Kate Rainczuk, Amy L Winship, Karla J Hutt

Reproductive BioMedicine Online · 2026

DOI: 10.1016/j.rbmo.2026.105885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Yujie Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ovarian Biology Laboratory, Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Development and Stem Cells Program, Mon…. Hauptthemen laut MEDLINE: Oocytes, Ovarian Follicle, Ovulation, BRCA1 Protein. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rebecca L Cooper Medical Research Foundation, National Health and Medical Research Council, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Does oocyte-specific loss of breast cancer susceptibility gene 1 (Brca1) increase vulnerability to chemotherapy-induced ovarian damage in mice? DESIGN: This study examined the effects of chemotherapeutic agents, including cyclophosphamide, doxorubicin, paclitaxel and carboplatin, on ovarian function in mice with oocyte-specific Brca1 deletion [conditional knockout (cKO): Brca1fl/flGdf9cre/+] and wild-type controls (Brca1fl/flGdf9+/+). Young (40-80 postnatal days) and older (180-220 postnatal days) mice received a single dose of chemotherapy or saline, and ovarian reserve, serum anti-Müllerian hormone, and ovulated oocytes were assessed. RESULTS: In young wild-type mice, doxorubicin depleted the number of primordial follicles significantly (P = 0.0082), whereas cyclophosphamide, paclitaxel and carboplatin at the chosen doses did not reduce the number of primordial follicles significantly. Importantly, loss of primordial follicles was not exacerbated by any chemotherapeutic agent in cKO mice compared with wild-type mice. Follicle atresia and granulosa cell apoptosis were unaffected by treatment or genotype. In older mice, paclitaxel and carboplatin impaired superovulation and reduced the yield of mature (metaphase II) oocytes in cKO mice, while ovarian reserve, including primordial and primary follicles, remained largely preserved. CONCLUSIONS: These results indicate that Brca1 deficiency in mice reduced ovulatory capacity after chemotherapy in older females without altering the number of follicles substantially. These findings underscore the need to consider BRCA1 status in fertility preservation counselling and interventions for women undergoing chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OocytesOvarian FollicleOvulationBRCA1 ProteinAntineoplastic AgentsAnimalsFemaleMiceMice, KnockoutOvarian ReserveDoxorubicinCyclophosphamidePaclitaxelCarboplatinFollicular AtresiaApoptosisAnti-Mullerian Hormone

Stichwörter der Autor:innen

AgeingBRCA1ChemotherapyDNA repairOocyteOvulation

Substanzen

BRCA1 ProteinAntineoplastic AgentsDoxorubicinCyclophosphamidePaclitaxelBrca1 protein, mouseCarboplatinAnti-Mullerian Hormone

Autor:innen und Institutionen

  • Ovarian Biology Laboratory, Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Development and Stem Cells Program, Monash University, Clayton, Victoria, Australia.
  • Ovarian Biology Laboratory, Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Development and Stem Cells Program, Monash University, Clayton, Victoria, Australia. Electronic address: amy.…
  • Ovarian Biology Laboratory, Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Development and Stem Cells Program, Monash University, Clayton, Victoria, Australia. Electronic address: karl…

Förderung

  • Rebecca L Cooper Medical Research Foundation
  • National Health and Medical Research Council
  • Australian Research Council

Zitieren

APA

Cao, Y., Lewis, Y., Tu, L., Alesi, L. R., Stringer, J. M., Zerafa, N., Rainczuk, K., Winship, A. L., & Hutt, K. J. (2026). BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2026.105885

Vancouver

Cao Y, Lewis Y, Tu L, Alesi LR, Stringer JM, Zerafa N, et al. BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2026.105885

BibTeX
@article{Cao2026,
  author = {Cao, Yujie and Lewis, Yasmin and Tu, Lisa and Alesi, Lauren R and Stringer, Jessica M and Zerafa, Nadeen and Rainczuk, Kate and Winship, Amy L and Hutt, Karla J},
  title = {BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice},
  journal = {Reproductive BioMedicine Online},
  year = {2026},
  doi = {10.1016/j.rbmo.2026.105885}
}
Kostenlos starten →